Clever Culture Systems Limited
CC5
Pozycja w akcjach
#27512
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Cena akcji
$0.0141057
Ostatnia synchronizacja: 2026-10-18
Kapitalizacja rynkowa
$30.78M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
32.83%
Kraj
AU
Handel Clever Culture Systems Limited (CC5)
Kategoria
Healthcare
Zyski dla Clever Culture Systems Limited (CC5)
Zyski w Jun 2024 TTM: $-3.12M
Według najnowszych raportów finansowych Clever Culture Systems Limited, obecny zysk firmy wynosi $-3.12M. W roku 2023 firma osiągnęła zysk w wysokości $-13.91M, spadek w porównaniu do zysku z roku 2022, który wynosił $-5.66M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Clever Culture Systems Limited od 2007 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $-3.12M | 0.00% |
| 2024 | $-3.12M | -77.57% |
| 2023 | $-13.91M | 145.86% |
| 2022 | $-5.66M | 30.43% |
| 2021 | $-4.34M | 11.28% |
| 2020 | $-3.90M | -7.37% |
| 2019 | $-4.21M | 73.60% |
| 2018 | $-2.42M | -67.23% |
| 2017 | $-7.40M | -341.08% |
| 2016 | $3.07M | -1,286.43% |
| 2015 | $-258.70K | -71.75% |
| 2014 | $-915.89K | -370.88% |
| 2013 | $338.11K | -119.00% |
| 2012 | $-1.78M | -10.68% |
| 2011 | $-1.99M | -219.96% |
| 2010 | $1.66M | 689.45% |
| 2009 | $210.37K | -2.53% |
| 2008 | $215.84K | -77.99% |
| 2007 | $980.77K | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $7.61B | -243,863.06% |
US
|
|
| $4.76B | -152,656.14% |
US
|
|
| $-252.70M | 7,995.57% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -53,215.93% |
US
|
